Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01422837 · ClinicalTrials.gov registry record
ALK21-025: Vivitrol's Cost and Treatment Outcomes Registry
A clinical trial of Opioid Dependence, sponsored by Alkermes.
- Completed
- Registry status
- 403
- Enrollment target
- 20
- Study locations
NCT01422837 is a study of Opioid Dependence that has completed, run by Alkermes. The registered enrollment target is 403 participants, above the 144-participant average among 29 other Opioid Dependence trials with a reported enrollment target (180% higher). The trial reports 20 study locations across 11 states.
The verdict
NCT01422837, a study of Opioid Dependence, has completed, sponsored by Alkermes.
- COMPLETED
- Registry status
- 403 participants
- Enrollment target
- 20
- Study locations
Study Summary
The objective of the VIVITROL Registry is to gather real world data on opioid dependence and to provide understanding of the health economics of opioid dependence.
Conditions Studied
Study Locations (20)
California
- Amy Solomon, MD - Ben Lomond
- Touchstone Medical Group - Clovis
- Kenneth C. Russ, MD - Palm Springs
- Tarzana Treatment Centers - Tarzana
New York
- Dent Neurologic Institute - Amherst
- Dr. Michael Sanders - Great Neck
- Fakhouri Medical - Hopewell Junction
- Parallax Center - New York
Florida
- Jacqueline Boutrouille, MD - Tamarac
- Alliance Clinical Research - Winter Park
Georgia
- Atlanta Institute of Medicine and Research - Atlanta
- PACT Atlanta - Decatur
Massachusetts
- Gosnold-Thorne Counseling Center - Centerville
- Dr. Li's Clinic - Milford
Arizona
- Assisted Recovery Centers of America - Phoenix
Arkansas
- Arkansas Psychiatric Clinc - Little Rock
Colorado
- The NeuroBehavioral Institute of Colorado, PC - Lone Tree
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 403 participants |
| Start Date | 2011-08 |
| Est. Completion | 2013-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01422837
The ClinicalTrials.gov registry entry for NCT01422837 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 403 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 144-participant average among 29 other Opioid Dependence trials with a reported enrollment target (180% higher). The listed sponsor is Alkermes, which has 66 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Opioid Dependence appearing as the primary indexed condition, and to 0 interventions.
NCT01422837 reports 20 study locations spanning 11 distinct geographic areas - top geographies include California, New York, Florida.
Frequently Asked Questions
What is clinical trial NCT01422837 about?
NCT01422837 is a clinical study titled "ALK21-025: Vivitrol's Cost and Treatment Outcomes Registry". The objective of the VIVITROL Registry is to gather real world data on opioid dependence and to provide understanding of the health economics of opioid dependence.
What is the current status of trial NCT01422837?
This trial is currently completed. The enrollment target is 403 participants. The study started on 2011-08. Estimated completion is 2013-10.
What conditions does trial NCT01422837 study?
This clinical trial studies the following conditions: Opioid Dependence.
Who is sponsoring clinical trial NCT01422837?
This trial is sponsored by Alkermes, which has 66 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01422837 being conducted?
This trial has 20 study locations across Arizona, Arkansas, California, Colorado, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Neuromodulation and Cognitive Training in Opioid Use Disorder
RECRUITING · NA
-
Intervening With Opioid-Dependent MothersMothers and Infants
RECRUITING · NA
-
fMRI and Opioid Abstinence
RECRUITING
-
Better Options for Chronic Cancer Pain
RECRUITING · Phase 4
-
Young Houston Emergency Opioid Engagement System
RECRUITING · Phase 4
-
Buprenorphine as a Post-operative Analgesic in Opioid-Naive Patients After Ankle Fracture Surgery
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.